sst2 Somatostatin Receptor Mediates Negative Regulation of Insulin Receptor Signaling through the Tyrosine Phosphatase SHP-1
Open Access
- 1 March 1998
- journal article
- Published by Elsevier
- Vol. 273 (12) , 7099-7106
- https://doi.org/10.1074/jbc.273.12.7099
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Both SH2 Domains Are Involved in Interaction of SHP-1 with the Epidermal Growth Factor Receptor but Cannot Confer Receptor-directed Activity to SHP-1/SHP-2 ChimeraJournal of Biological Chemistry, 1997
- G-protein βγ Subunits Mediate Specific Phosphorylation of the Protein-tyrosine Phosphatase SH-PTP1 Induced by Lysophosphatidic AcidPublished by Elsevier ,1996
- Association of SH2 Domain Protein Tyrosine Phosphatases with the Epidermal Growth Factor Receptor in Human Tumor Cells: PHOSPHATIDIC ACID ACTIVATES RECEPTOR DEPHOSPHORYLATION BY PTP1CPublished by Elsevier ,1995
- The somatostatin receptor familyLife Sciences, 1995
- Recruitment and Activation of PTP1C in Negative Regulation of Antigen Receptor Signaling by FcγRIIB1Science, 1995
- Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signalsCell, 1995
- Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1–5, in transfected COS‐7 cellsFEBS Letters, 1994
- Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cellsEuropean Journal of Biochemistry, 1992
- A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transductionCell, 1992
- Human insulin receptor and its relationship to the tyrosine kinase family of oncogenesNature, 1985